Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology

Although kinase inhibitors (KI) frequently portray large interpatient variability, a ‘one size fits all’ regimen is still often used. In the meantime, relationships between exposure-response and exposure-toxicity have been established for several KIs, so this regimen could lead to unnecessary toxici...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Kleij, Maud B. A., Guchelaar, Niels A. D., Mathijssen, Ron H. J., Versluis, Jurjen, Huitema, Alwin D. R., Koolen, Stijn L. W., Steeghs, Neeltje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519871/
https://www.ncbi.nlm.nih.gov/pubmed/37584840
http://dx.doi.org/10.1007/s40262-023-01293-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519871/
https://www.ncbi.nlm.nih.gov/pubmed/37584840
http://dx.doi.org/10.1007/s40262-023-01293-9

Ejemplares similares